Discover open access scientific publications

Search, annotate, share and cite publications

Publications by R. Lilenbaum

OA10.04 Afatinib With or Without Cetuximab for EGFR-Mutant Non-Small Cell Lung Cancer: Safety and Efficacy Results From SWOG S1403

Journal of Thoracic Oncology

Respiratory Medicine

English

Related publications

Dual Inhibition of EGFR With Afatinib and Cetuximab in Kinase Inhibitor-Resistant EGFR-Mutant Lung Cancer With and Without T790M Mutations

Cancer Discovery

English

Afatinib in Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations Pretreated With Reversible EGFR Inhibitors

Cancer Research

English

Enhanced Efficacy of AZD3759 and Radiation on Brain Metastasis From EGFR Mutant Non-Small Cell Lung Cancer

International Journal of Cancer

Cancer Research

English

P3.13-22 Real World Study of Afatinib in First-Line or Re-Challenge Setting for Patients With EGFR Mutant Non-Small Cell Lung Cancer.

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.13-15 First-Line Afatinib Dose Initiation and Adjustment in Patients With EGFR Mutant Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.15-21 Real-World Experience of First-Line Afatinib Treatment in Patients With EGFR Mutant Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

Third Generation EGFR TKI Landscape for Metastatic EGFR Mutant Non-Small Cell Lung Cancer (NSCLC)

Expert Review of Anticancer Therapy

English

Clinical Efficacy and Safety of Afatinib in the Treatment of Non-Small-Cell Lung Cancer in Chinese Patients

OncoTargets and Therapy

English

Efficacy of EGFR-TKIs With or Without Angiogenesis Inhibitors in Advanced Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis

Journal of Cancer

English